Prevalence and sociodemographic determinants of dyspepsia in the general population of Rwanda.
Adult
Alcohol Drinking
/ adverse effects
Anti-Inflammatory Agents, Non-Steroidal
/ adverse effects
Aspirin
/ adverse effects
Case-Control Studies
Cost of Illness
Cross-Sectional Studies
Demography
/ statistics & numerical data
Dyspepsia
/ chemically induced
Female
Humans
Male
Middle Aged
Prevalence
Quality of Life
Risk Factors
Rwanda
/ epidemiology
Severity of Illness Index
Smoking
/ adverse effects
Social Class
Surveys and Questionnaires
/ statistics & numerical data
dyspepsia
epidemiology
quality of life
Journal
BMJ open gastroenterology
ISSN: 2054-4774
Titre abrégé: BMJ Open Gastroenterol
Pays: England
ID NLM: 101660690
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
12
02
2020
revised:
09
03
2020
accepted:
27
03
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
20
7
2021
Statut:
ppublish
Résumé
Dyspepsia accounts for a significant burden of worldwide disease, but there is a relative paucity of data from the sub-Saharan African setting. We undertook to describe the burden, risk factors and severity of dyspepsia across Rwanda. We performed a population-based clustered cross-sectional survey between November 2015 and January 2016, nationwide in Rwanda, using the Short Form Leeds Dyspepsia Questionnaire to describe the presence and severity of dyspepsia, and the Short Form Nepean Dyspepsia Index to describe the concomitant quality of life effects. Univariate and multivariate logistic regression models were constructed to correlate measured sociodemographic factors with dyspepsia. The prevalence of clinically significant dyspepsia in the general Rwandan population was 14.2% (283/2000). The univariate factors that significantly predicted severity were gender, profession, socioeconomic status, and non-steroidal anti-inflammatory drug, aspirin and alcohol use, with gender, current smoking, aspirin use both in the past and currently, and alcohol use in the past remaining significant on multivariate modelling. Dyspeptics had a significantly lower gastrointestinal-related quality of life, though the sociodemographic factors measured did not modify the observed quality of life. Dyspepsia is prevalent in the Rwandan setting and is associated with a significant burden on quality of life. More work is required to determine the pathological entities involved, and the optimal approach to mitigating this burden.
Identifiants
pubmed: 32381743
pii: bmjgast-2020-000387
doi: 10.1136/bmjgast-2020-000387
pmc: PMC7222881
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
East Afr Med J. 2002 May;79(5):232-6
pubmed: 12638805
BMC Gastroenterol. 2018 Jan 18;18(1):13
pubmed: 29347978
J Gastroenterol Hepatol. 2011 Nov;26(11):1669-76
pubmed: 21649731
Anat Rec (Hoboken). 2010 Sep;293(9):1536-42
pubmed: 20648573
Gut. 2015 Jul;64(7):1049-57
pubmed: 25147201
J Manag Care Pharm. 2013 Nov-Dec;19(9):755-64
pubmed: 24156644
Am J Gastroenterol. 1999 Sep;94(9):2390-7
pubmed: 10483997
World J Gastroenterol. 2009 Jul 7;15(25):3173-7
pubmed: 19575499
Eur J Gastroenterol Hepatol. 1995 Oct;7(10):985-7
pubmed: 8590146
Scand J Gastroenterol Suppl. 1999;231:29-37
pubmed: 10565621
BMJ Open. 2016 Jun 06;6(6):e011018
pubmed: 27266772
Turk J Gastroenterol. 2004 Jun;15(2):86-9
pubmed: 15334316
Am J Gastroenterol. 2004 Nov;99(11):2210-6
pubmed: 15555004
Ugeskr Laeger. 1982 Jan 25;144(4):267-73
pubmed: 7071969
Gastroenterology. 1981 Aug;81(2):376-94
pubmed: 7016659
Indian J Gastroenterol. 2001 May-Jun;20(3):103-6
pubmed: 11400800
Gastroenterology. 2018 Feb;154(3):500-514
pubmed: 29221664
Trop Geogr Med. 1991 Jan-Apr;43(1-2):209-14
pubmed: 1750117
Afr J Med Med Sci. 1996 Mar;25(1):23-9
pubmed: 9110051
Am J Gastroenterol. 2013 Feb;108(2):270-6
pubmed: 23295280
J Gastroenterol Hepatol. 2014 Mar;29(3):474-9
pubmed: 24304041
Aliment Pharmacol Ther. 2007 Feb 15;25(4):477-86
pubmed: 17270004
S Afr Med J. 2015 Nov 06;105(12):1064-9
pubmed: 26792168
Alcohol Health Res World. 1997;21(1):76-83
pubmed: 15706765
Aliment Pharmacol Ther. 2010 May;31(10):1141-51
pubmed: 20175766
Aliment Pharmacol Ther. 2011 Jun;33(11):1215-24
pubmed: 21443537
Aliment Pharmacol Ther. 2001 Feb;15(2):207-16
pubmed: 11148439
Scand J Gastroenterol. 2006 Feb;41(2):149-54
pubmed: 16484119
J Pak Med Assoc. 2012 Jul;62(7):672-6
pubmed: 23866513
Aliment Pharmacol Ther. 2000 Apr;14(4):413-20
pubmed: 10759620
Indian J Gastroenterol. 2000 Apr-Jun;19(2):68-70
pubmed: 10812818
Arch Intern Med. 1998 Jul 13;158(13):1427-33
pubmed: 9665351
Health Qual Life Outcomes. 2009 May 23;7:45
pubmed: 19463190
Middle East J Dig Dis. 2010 Jan;2(1):24-30
pubmed: 25197509
N Engl J Med. 2015 Nov 5;373(19):1853-63
pubmed: 26535514
Am J Gastroenterol. 2000 Jun;95(6):1448-55
pubmed: 10894577